HSBC Holdings’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.1M | Sell |
355,417
-1,605
| -0.4% | -$147K | 0.02% | 628 |
|
|
2025
Q4 | $32.2M | Sell |
357,022
-9,335
| -3% | -$885K | 0.02% | 613 |
|
|
2025
Q3 | $36.1M | Sell |
366,357
-7,148
| -2% | -$708K | 0.02% | 558 |
|
|
2025
Q2 | $34.1M | Sell |
373,505
-62,332
| -14% | -$6.03M | 0.02% | 562 |
|
|
2025
Q1 | $49.3M | Sell |
435,837
-3,254
| -0.7% | -$348K | 0.03% | 484 |
|
|
2024
Q4 | $46.4M | Buy |
439,091
+11,329
| +3% | +$1.22M | 0.03% | 501 |
|
|
2024
Q3 | $46.1M | Sell |
427,762
-150,358
| -26% | -$16.4M | 0.03% | 501 |
|
|
2024
Q2 | $62.7M | Buy |
578,120
+166,172
| +40% | +$19.6M | 0.04% | 397 |
|
|
2024
Q1 | $54.3M | Sell |
411,948
-226,253
| -35% | -$28.3M | 0.04% | 444 |
|
|
2023
Q4 | $77.7M | Sell |
638,201
-52,344
| -8% | -$5.84M | 0.07% | 295 |
|
|
2023
Q3 | $77.6M | Buy |
690,545
+53,250
| +8% | +$6.76M | 0.08% | 249 |
|
|
2023
Q2 | $92.8M | Buy |
637,295
+100,084
| +19% | +$13.6M | 0.09% | 204 |
|
|
2023
Q1 | $69.4M | Sell |
537,211
-74,599
| -12% | -$9.37M | 0.08% | 245 |
|
|
2022
Q4 | $77.9M | Buy |
611,810
+146,534
| +31% | +$17M | 0.09% | 230 |
|
|
2022
Q3 | $48.9M | Sell |
465,276
-9,281
| -2% | -$1.02M | 0.08% | 250 |
|
|
2022
Q2 | $50M | Sell |
474,557
-31,430
| -6% | -$3.73M | 0.07% | 278 |
|
|
2022
Q1 | $64.8M | Sell |
505,987
-12,036
| -2% | -$1.45M | 0.08% | 238 |
|
|
2021
Q4 | $64M | Sell |
518,023
-17,489
| -3% | -$2.29M | 0.06% | 316 |
|
|
2021
Q3 | $76.4M | Sell |
535,512
-95,358
| -15% | -$14M | 0.08% | 213 |
|
|
2021
Q2 | $98.5M | Buy |
630,870
+108,859
| +21% | +$17.6M | 0.11% | 178 |
|
|
2021
Q1 | $81.5M | Buy |
522,011
+112,481
| +27% | +$17.4M | 0.1% | 201 |
|
|
2020
Q4 | $61M | Buy |
409,530
+40,350
| +11% | +$5.7M | 0.08% | 231 |
|
|
2020
Q3 | $48.7M | Buy |
369,180
+41,003
| +12% | +$5.36M | 0.08% | 234 |
|
|
2020
Q2 | $38M | Sell |
328,177
-31,274
| -9% | -$3.6M | 0.07% | 254 |
|
|
2020
Q1 | $35.1M | Buy |
359,451
+54,465
| +18% | +$7.14M | 0.08% | 225 |
|
|
2019
Q4 | $44.2M | Buy |
304,986
+9,203
| +3% | +$1.27M | 0.08% | 253 |
|
|
2019
Q3 | $39.4M | Sell |
295,783
-9,443
| -3% | -$1.22M | 0.07% | 287 |
|
|
2019
Q2 | $34.9M | Buy |
305,226
+72,646
| +31% | +$8.51M | 0.07% | 301 |
|
|
2019
Q1 | $28.8M | Buy |
232,580
+154
| +0.1% | +$17.5K | 0.05% | 366 |
|
|
2018
Q4 | $23.4M | Sell |
232,426
-6,556
| -3% | -$737K | 0.04% | 435 |
|
|
2018
Q3 | $30.5M | Buy |
238,982
+25,082
| +12% | +$2.98M | 0.05% | 399 |
|
|
2018
Q2 | $23.1M | Sell |
213,900
-139,784
| -40% | -$15.2M | 0.04% | 439 |
|
|
2018
Q1 | $37.4M | Sell |
353,684
-3,211
| -0.9% | -$373K | 0.06% | 327 |
|
|
2017
Q4 | $41.8M | Buy |
356,895
+4,649
| +1% | +$526K | 0.06% | 292 |
|
|
2017
Q3 | $40M | Sell |
352,246
-46,447
| -12% | -$5.36M | 0.06% | 290 |
|
|
2017
Q2 | $49.7M | Buy |
398,693
+65,589
| +20% | +$7.78M | 0.09% | 210 |
|
|
2017
Q1 | $39.5M | Buy |
333,104
+15,247
| +5% | +$1.73M | 0.08% | 246 |
|
|
2016
Q4 | $31.8M | Buy |
317,857
+27,873
| +10% | +$2.99M | 0.07% | 310 |
|
|
2016
Q3 | $36.6M | Sell |
289,984
-41,033
| -12% | -$5.07M | 0.09% | 246 |
|
|
2016
Q2 | $38.7M | Buy |
331,017
+23,842
| +8% | +$2.7M | 0.11% | 217 |
|
|
2016
Q1 | $31.8M | Sell |
307,175
-40,647
| -12% | -$3.93M | 0.09% | 263 |
|
|
2015
Q4 | $34.6M | Buy |
347,822
+43,654
| +14% | +$4.27M | 0.08% | 270 |
|
|
2015
Q3 | $27.7M | Buy |
304,168
+118,610
| +64% | +$11.9M | 0.07% | 310 |
|
|
2015
Q2 | $19.7M | Sell |
185,558
-217,467
| -54% | -$24.1M | 0.04% | 422 |
|
|
2015
Q1 | $46M | Buy |
403,025
+1,954
| +0.5% | +$223K | 0.09% | 240 |
|
|
2014
Q4 | $44.2M | Buy |
401,071
+34,298
| +9% | +$3.62M | 0.09% | 235 |
|
|
2014
Q3 | $35.8M | Sell |
366,773
-530,793
| -59% | -$52.2M | 0.08% | 263 |
|
|
2014
Q2 | $90.5M | Buy |
897,566
+433,181
| +93% | +$42.3M | 0.2% | 112 |
|
|
2014
Q1 | $42.6M | Sell |
464,385
-28,860
| -6% | -$2.66M | 0.1% | 207 |
|
|
2013
Q4 | $44.6M | Buy |
493,245
+134,847
| +38% | +$11.7M | 0.12% | 188 |
|
|
2013
Q3 | $28.6M | Buy |
358,398
+11,688
| +3% | +$920K | 0.08% | 291 |
|
|
2013
Q2 | $25.2M | Buy |
+346,710
| New | +$25.9M | 0.08% | 285 |
|
Other funds holding ZBH
VCM
VPM
HSBC Holdings's ZBH Position: Q1 2026 in Review
HSBC Holdings reduced its Zimmer Biomet (ZBH) stake by 0.45% in Q1 2026, selling an estimated $147K and leaving 355,417 shares worth $32.1M. The position accounts for 0.02% of the portfolio, ranked #628.
HSBC Holdings first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $98.5M in Q2 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- HSBC Holdings held 355,417 shares of Zimmer Biomet worth $32.1M as of Q1 2026.
- HSBC Holdings sold 1,605 Zimmer Biomet shares in Q1 2026, an estimated $147K.
- Zimmer Biomet made up 0.02% of HSBC Holdings's portfolio in Q1 2026, its #628 holding.
- HSBC Holdings first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Zimmer Biomet position peaked at $98.5M in Q2 2021.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.